National Institute on Drug Abuse Draft Strategic Plan, 1226 [E7-25521]
Download as PDF
<![CDATA[
1226
Federal Register / Vol. 73, No. 4 / Monday, January 7, 2008 / Notices
Agenda: (1) A report by the Director,
NICHD; (2) Obstetric and Pediatric
Pharmacology Branch Presentation; (3) a
report of the subcommittee on Planning and
Policy; and other business of the Council.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C-Wing,
Conference Room 6, Bethesda, MD 20892.
Closed: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C-Wing,
Conference Room 6, Bethesda, MD 20892.
Contact Person: Yvonne T. Maddox, PhD,
Deputy Director, National Institute of Child
Health and Human Development, NIH, 9000
Rockville Pike MSC 7510, Building 31, Room
2A03, Bethesda, MD 20892, (301) 496–1848.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.nichd.nih.gov/about/nachhd.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program. National
Institutes of Health, HHS)
Dated: December 27, 2007.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–6292 Filed 01–04–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
pwalker on PROD1PC71 with NOTICES
National Institute of Mental Health;
Notice of Workshops
Notice is hereby given of a series of
four scientific workshops organized by
the Interagency Autism Coordinating
Committee (IACC).
The workshops will be closed to the
public with attendance limited to
invited participants. The purpose of the
scientific workshops is to generate
research priorities that will be used to
VerDate Aug<31>2005
19:05 Jan 04, 2008
Jkt 214001
develop the IACC strategic plan for
Autism Spectrum Disorder (ASD)
research. The next meeting of the IACC
when research priorities will be
discussed is March 14, 2008.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Type of meeting: Scientific workshops.
Date: January 15–18, 2008.
Time: 9 a.m. to 5 p.m. each day.
Agenda: Review of research
accomplishments, funding initiatives and
research resources for ASD by scientists and
other ASD stakeholders; discussion and
generation of high priority research areas and
initiatives for developing the IACC strategic
plan for ASD research.
Place: The Westin Arlington Gateway, 801
North Glebe Road, Arlington, VA 22203,
703–717–6200.
Contact Person: Joyce Y. Chung, MD,
Interagency Autism Coordinating Committee,
National Institute of Mental Health, NIH,
6001 Executive Boulevard, NSC, Room 6198,
Bethesda, MD 20892–9669, 301–443–3621.
Information about the IACC is available on
the Web site: https://www.nimh.nih.gov/
research-funding/scientific-meetings/
recurring-meetings/iacc/index.shtml.
Dated: December 27, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–6293 Filed 1–4–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse Draft
Strategic Plan
National Institute on Drug
Abuse, NIH, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The National Institute on
Drug Abuse (NIDA) is developing a
strategic plan for the next 5 years, and
invites the public to provide comments
on a draft of this plan. The draft plan
will be publicly available through the
NIDA Draft Strategic Plan Web page
(https://www.drugabuse.gov/
StrategicPlan/) for 30 days
from the publication of this Notice. The
public is invited to provide comments
via the e-mail address or the postal
address listed on the NIDA Draft
Strategic Plan Web page.
Background: NIDA is the lead Federal
agency for research on drug abuse and
addiction. For the past three decades,
NIDA has led the way in supporting
research to prevent and treat drug abuse
and addiction and mitigate the impact
of their consequences—particularly the
spread of HIV/AIDS and other infectious
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
diseases. Given recent revolutionary
advances in drug abuse research, NIDA
has recently undergone a strategic
planning process gathering
recommendations from the National
Advisory Council on Drug Abuse and
from ongoing dialogue with our various
stakeholder groups to establish
achievable goals and objectives for the
future.
NIDA’s draft Strategic Plan outlines
four major goal areas—Prevention,
Treatment, HIV/AIDS, and Cross Cutting
Priorities—each with Strategic
Objectives that will guide NIDA’s
research agenda for the future. The
public is invited to review this draft
plan and provide comments. The draft
plan may be viewed at https://
www.drugabuse.gov/StrategicPlan/
Index.html, and hard copies are
available by calling 301–443–1124 or by
sending a letter requesting a copy (that
includes your mailing address) to:
National Institute on Drug Abuse, Attn:
Draft Strategic Plan, 6001 Executive
Blvd., Suite 5213, MSC 9561, Bethesda,
MD 20892–9561.
Request for Comments: The public is
invited to provide comments on the
draft Strategic Plan. Comments may be
sent to the email address listed on the
NIDA Strategic Planning Web page at
https://www.drugabuse.gov/
StrategicPlan/, or to the
postal address listed above.
Comments Due Date: Comments
regarding NIDA’s draft Strategic Plan
should be submitted via e-mail to
stratplan@nida.nih.gov no later than 30
days after the publication of this Notice.
Comments mailed to the above postal
address must be postmarked by the
same date.
Dated: December 21, 2007.
Nora D. Volkow,
Director, National Institute on Drug Abuse,
National Institutes of Health.
[FR Doc. E7–25521 Filed 1–4–08; 11:28 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5121–N–35]
Notice of Proposed Information
Collection: Comment Request Loan
Sales Bidder Qualification Statement
Office of the Assistant
Secretary for Housing—Federal Housing
Commissioner, HUD.
ACTION: Notice.
AGENCY:
SUMMARY: The proposed information
collection requirement described below
will be submitted to the Office of
E:\FR\FM\07JAN1.SGM
07JAN1
]]>Agencies
[Federal Register Volume 73, Number 4 (Monday, January 7, 2008)]
[Notices]
[Page 1226]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-25521]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse Draft Strategic Plan
AGENCY: National Institute on Drug Abuse, NIH, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Institute on Drug Abuse (NIDA) is developing a
strategic plan for the next 5 years, and invites the public to provide
comments on a draft of this plan. The draft plan will be publicly
available through the NIDA Draft Strategic Plan Web page (https://
www.drugabuse.gov/StrategicPlan/) for 30 days from the
publication of this Notice. The public is invited to provide comments
via the e-mail address or the postal address listed on the NIDA Draft
Strategic Plan Web page.
Background: NIDA is the lead Federal agency for research on drug
abuse and addiction. For the past three decades, NIDA has led the way
in supporting research to prevent and treat drug abuse and addiction
and mitigate the impact of their consequences--particularly the spread
of HIV/AIDS and other infectious diseases. Given recent revolutionary
advances in drug abuse research, NIDA has recently undergone a
strategic planning process gathering recommendations from the National
Advisory Council on Drug Abuse and from ongoing dialogue with our
various stakeholder groups to establish achievable goals and objectives
for the future.
NIDA's draft Strategic Plan outlines four major goal areas--
Prevention, Treatment, HIV/AIDS, and Cross Cutting Priorities--each
with Strategic Objectives that will guide NIDA's research agenda for
the future. The public is invited to review this draft plan and provide
comments. The draft plan may be viewed at https://www.drugabuse.gov/
StrategicPlan/, and hard copies are available by calling 301-
443-1124 or by sending a letter requesting a copy (that includes your
mailing address) to: National Institute on Drug Abuse, Attn: Draft
Strategic Plan, 6001 Executive Blvd., Suite 5213, MSC 9561, Bethesda,
MD 20892-9561.
Request for Comments: The public is invited to provide comments on
the draft Strategic Plan. Comments may be sent to the email address
listed on the NIDA Strategic Planning Web page at https://
www.drugabuse.gov/StrategicPlan/, or to the postal address
listed above.
Comments Due Date: Comments regarding NIDA's draft Strategic Plan
should be submitted via e-mail to stratplan@nida.nih.gov no later than
30 days after the publication of this Notice. Comments mailed to the
above postal address must be postmarked by the same date.
Dated: December 21, 2007.
Nora D. Volkow,
Director, National Institute on Drug Abuse, National Institutes of
Health.
[FR Doc. E7-25521 Filed 1-4-08; 11:28 am]
BILLING CODE 4140-01-P
